Unknown

Dataset Information

0

The crosstalk between non-coding RNA polymorphisms and resistance to lung cancer therapies.

ABSTRACT: Lung cancer (LC) is one of the most common cancer-related mortality in the world. Even with intensive multimodality therapies, lung cancer has a poor prognosis and a high morbidity rate. This review focused on the role of non-coding RNA polymorphisms such as lncRNAs and miRNAs in the resistance to LC therapies, which could open promising avenue for better therapeutic response. Of note, there is currently no valid biomarker to predict lung cancer sensitivity in patients during treatment. Since genetic variations cause many challenges in treating patients, genotyping of known polymorphisms must be thoroughly explored to find desirable treatment platforms. With this knowledge, individualized treatments could become more possible in management of LC.

SUBMITTER: Mollazadeh S 

PROVIDER: S-EPMC10565774 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The crosstalk between non-coding RNA polymorphisms and resistance to lung cancer therapies.

Mollazadeh Samaneh S   Abdolahzadeh Negar N   Moghbeli Meysam M   Arab Fatemeh F   Saburi Ehsan E  

Heliyon 20231004 10

Lung cancer (LC) is one of the most common cancer-related mortality in the world. Even with intensive multimodality therapies, lung cancer has a poor prognosis and a high morbidity rate. This review focused on the role of non-coding RNA polymorphisms such as lncRNAs and miRNAs in the resistance to LC therapies, which could open promising avenue for better therapeutic response. Of note, there is currently no valid biomarker to predict lung cancer sensitivity in patients during treatment. Since ge  ...[more]